> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# ANDA Consolidation MAPP
- URL: https://www.fdaweb.com/anda-consolidation-mapp/
- Published: 2020-08-19T12:00:00.000Z
- Updated: 2026-09-14T16:25:28.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5147469

CBER has issued a Manual of Policies and Procedures (MAPP), *Consolidation of ANDAs by the Office of Generic Drugs*, describing the process for reviewing and approving or denying requests to consolidate previously approved ANDAs submitted by an ANDA applicant. The [MAPP](https://www.fda.gov/media/141312/download?ref=fdaweb.com) applies to the Office of Generic Drugs (OGD) ANDA consolidation coordination, who coordinates the requests for consolidation, determines whether any of the ANDAs identified in a request for consolidation have associated open or outstanding issues, makes the consolidation determination, and ensures ANDAs are properly consolidated. It also applies to OGD regulatory project managers (RPMs) and document room staff who forward consolidation requests to the OGD RPMs.